Mandana Nikpour

Correspondence to 'Time to change the primary outcome of lupus trials'

Shereen Oon, Molla Huq, Mandana Nikpour

Journal article  |  2021  |  ANNALS OF THE RHEUMATIC DISEASES

Immunosuppression does not prevent severe gastrointestinal tract involvement in systemic sclerosis.

Nicolas Richard, Geneviève Gyger, Sabrina Hoa, Susanna Proudman, Wendy Stevens, Mandana Nikpour, Mianbo Wang, Mireille E Schnitzer, Murray Baron, Marie Hudson, undefined Canadian Scleroderma Research Group (CSRG), Australian Scleroderma Interest Group (ASIG)

Journal article  |  2021  |  Clin Exp Rheumatol

OBJECTIVES: We aimed to test the hypothesis that exposure to immunosuppression in early systemic sclerosis (SSc) could modify the ..

How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials

Ioannis Parodis, Mandana Nikpour

Journal article  |  2021  |  ANNALS OF THE RHEUMATIC DISEASES

Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis.

Sabrina Hoa, Sasha Bernatsky, Murray Baron, Susanna Proudman, Wendy Stevens, Joanne Sahhar, Mianbo Wang, Russell J Steele, undefined Canadian Scleroderma Research Group (CSRG), undefined Australian Scleroderma Interest Group (ASIG), Mandana Nikpour, Marie Hudson

Journal article  |  2021  |  Chest

Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes

Zoe Brown, Susanna Proudman, Kathleen Morrisroe, Wendy Stevens, Dylan Hansen, Mandana Nikpour

Journal article  |  2021  |  SEMINARS IN ARTHRITIS AND RHEUMATISM

BACKGROUND: Systemic sclerosis (scleroderma, SSc) is a chronic multisystem autoimmune disease characterised by fibrosis of the ski..

POS0753 SUBSPECIALTY LUPUS CLINIC CARE IS ASSOCIATED WITH HIGHER QUALITY FOR PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

S Sreedharan, A Hoi, N Li, G Littlejohn, R Buchanan, M Nikpour, EF Morand, V Golder

Journal article  |  2021  |  Annals of the Rheumatic Diseases

Background:Healthcare quality for systemic lupus erythematosus (SLE) is a modifiable target for improving patient outcomes. Diseas..

Overlap syndrome of systemic sclerosis and systemic lupus erythematosus with renal involvement

Rushab Shah, Shreeya Patel, Simin Daneshvar, Mandana Nikpour

Journal article  |  2021  |  INTERNAL MEDICINE JOURNAL

Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients

AYS Lee, KA Patterson, DJ Tan, ME Wilson, SM Proudman, W Stevens, M Nikpour, J Sahhar, G-S Ngian, J Roddy, PJ Roberts-Thomson, JG Walker

Journal article  |  2021  |  SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Objective: We undertook a comprehensive cross-sectional analysis of a multicentred Australian cohort of systemic sclerosis (SSc) p..

Cost‐Effectiveness of Combination Therapy for Patients With Systemic Sclerosis–Related Pulmonary Arterial Hypertension

An Tran‐Duy, Kathleen Morrisroe, Philip Clarke, Wendy Stevens, Susanna Proudman, Joanne Sahhar, Mandana Nikpour

Journal article  |  2021  |  Journal of the American Heart Association

Background: To evaluate the cost‐effectiveness of combination pulmonary arterial hypertension specific therapy in systemic scleros..

Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes

Jessica L Fairley, Dylan Hansen, Susanna Proudman, Joanne Sahhar, Gene-Siew Ngian, Jenny Walker, Gemma Strickland, Michelle Wilson, Kathleen Morrisroe, Nava Ferdowsi, Gabor Major, Janet Roddy, Wendy Stevens, Mandana Nikpour

Journal article  |  2021  |  ARTHRITIS CARE & RESEARCH

OBJECTIVE: To describe the clinical characteristics and outcomes of systemic sclerosis-mixed connective tissue disease (SSc-MCTD) ..